CXCR4 antagonists (Leo Pharma)

N/A

Report date: 2025/03/18 20:00:05

NME

Base Information

Drug NameCXCR4 antagonists (Leo Pharma)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonists

TargetsC-X-C motif chemokine receptor 4

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesLeo Pharma A/S

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesLeo Pharma A/S

Active IndicationsN/A

Inactive IndicationsAutoimmune Diseases

ATC CodeN/A